๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Catching up with history: Treatment of Wilms' tumor in a developing country

โœ Scribed by De Camargo, Beatriz ;De Andrea, Maria Lydia M. ;Franco, Eduardo L. F.

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
551 KB
Volume
15
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis

Despite the tremendous progress that pediatric oncology has achieved in the treatment of Wilms' tumor over the last several decades, survival rates in our institution b e fore 1970 did not exceed 8%. In order to correct the problem standardized therapy was instituted in 1970 through a multimodal oncological team. Results using the new approach were reviewed in 1979 (50 patients) and showed an overall 34% 2-year survival rate. Although encouraging, these results were still far below the ones reported in the literature. This prompted us to use a vigorous professional and lay educational program in the city. Treatment methods were replaced by those advocated by the Second National

๐Ÿ“œ SIMILAR VOLUMES

A randomized clinical trial of single-do
A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of wilms' tumor. Results after extended follow-up
โœ Beatriz De Camargo; Eduardo L. Franco; Brazilian Wilms' Tumor Study Group ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 500 KB

for the Brazilian Wilms' Tumor Study Group$ Background. To verify the adequacy of a simplified chemotherapeutic regimen for the treatment of Wilms' tumor (WT), the authors conducted a clinical trial to compare the standard fractionated dose (15 mcg/kg x 5 days) of dactinomycin (AMD) with a single do

Radiotherapy omitted in the treatment of
Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor
โœ Pachnis, A.; Pritchard, J.; Gaze, M.; Levitt, G.; Michalski, A. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB ๐Ÿ‘ 3 views

Background. Current treatment of stage III favorable histology (FH) Wilms tumor is surgery, radiotherapy to residual disease, and ''triple'' chemotherapy (vincristine, dactinomycin, and doxorubicin) for 12 months. This study tests the hypothesis that some stage III patients, especially very young ch